IBEX Limited

IBEX Limited Q4 2026 Earnings Recap

IBEX Q4 2026 September 12, 2026

Get alerts when IBEX reports next quarter

Set up alerts — free

IBEX’s shares rose 7.5% after the company reported 12% fourth-quarter revenue growth to $164.3 million and 15% full-year organic growth, alongside accelerating AI-agent traction and record profitability and cash-flow metrics.

Earnings Per Share Beat
$0.85 vs $0.84 est.
+0.6% surprise
Revenue Beat
164269000 vs 160022500 est.
+2.7% surprise

Market Reaction

Post-Earnings +7.45%

See IBEX alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Q4 revenue reached a record $164.3 million, up 12%; full-year revenue was $644.1 million, with organic growth of 15% and six consecutive quarters of double-digit growth.
  • IBEX added nine new “trophy” logos in Q4 and 17 for the full year; revenue from its top five, 10, and 25 clients grew 24%, 22%, and 15%, respectively.
  • HealthTech revenue grew 42% year over year in Q4 to $29.4 million and 38% for the full year to $114 million, surpassing the company’s $100 million target.
  • Client retention exceeded 99%, client NPS was 71, and employee NPS improved to 82 from 77, with 95% participation.
  • AI-agent deployments showed early traction: Philippine Airlines achieved resolution rates above 20% and CSAT above 4.7/5, while BJ’s Wholesale reached resolution rates above 40% and CSAT above 4.7/5.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit IBEX on AllInvestView.

Get the Full Picture on IBEX

Track IBEX Limited in your portfolio with real-time analytics, dividend tracking, and more.

View IBEX Analysis